Positive selection in the hemagglutinin-neuraminidase gene of Newcastle disease virus and its effect on vaccine efficacy

BackgroundTo investigate the relationship between the selective pressure and the sequence variation of the hemagglutinin-neuraminidase (HN) protein, we performed the positive selection analysis by estimating the ratio of non-synonymous to synonymous substitutions with 132 complete HN gene sequences of Newcastle disease viruses (NDVs) isolated in China.ResultsThe PAML software applying a maximum likelihood method was used for the analysis and three sites (residues 266, 347 and 540) in the HN protein were identified as being under positive selection. Codon 347 was located exactly in a recognized antigenic determinant (residues 345-353) and codon 266 in a predicted linear B-cell epitope. Substitutions at codon 540 contributed to the N-linked glycosylation potential of residue 538. To further evaluate the effect of positively selected sites on the vaccine efficacy, we constructed two recombinant fowlpox viruses rFPV-JS6HN and rFPV-LaSHN, expressing the HN proteins from a genotype VII field isolate Go/JS6/05 (with A266, K347 and A540) and vaccine strain La Sota (with V266, E347 and T540), respectively. Two groups of SPF chickens, 18 each, were vaccinated with the two recombinant fowlpox viruses and challenged by Go/JS6/05 at 3 weeks post-immunization. The results showed that rFPV-JS6HN could elicit more effective immunity against the prevalent virus infection than rFPV-LaSHN in terms of reducing virus shedding.ConclusionsThe analysis of positively selected codons and their effect on the vaccine efficacy indicated that the selective pressure on the HN protein can induce antigenic variation, and new vaccine to control the current ND epidemics should be developed.

[1]  L. McGinnes,et al.  Nucleotide sequence of the gene encoding the Newcastle disease virus hemagglutinin-neuraminidase protein and comparisons of paramyxovirus hemagglutinin-neuraminidase protein sequences. , 1987, Virus research.

[2]  L. Wang,et al.  Virology Journal , 1966, Nature.

[3]  S. Elankumaran,et al.  Role of fusion protein cleavage site in the virulence of Newcastle disease virus , 2003, Microbial Pathogenesis.

[4]  Shameek Biswas,et al.  Genomic insights into positive selection. , 2006, Trends in genetics : TIG.

[5]  Zhiliang Wang,et al.  Molecular characterization and phylogenetic analysis of new Newcastle disease virus isolates from the mainland of China. , 2008, Research in veterinary science.

[6]  T Gojobori,et al.  A method for detecting positive selection at single amino acid sites. , 1999, Molecular biology and evolution.

[7]  Zhiliang Wang,et al.  Molecular epidemiological analysis of Newcastle disease virus isolated in China in 2005. , 2007, Journal of virological methods.

[8]  D J Alexander,et al.  Newcastle disease and other avian paramyxoviruses. , 2000, Revue scientifique et technique.

[9]  B. Peeters,et al.  Rescue of Newcastle Disease Virus from Cloned cDNA: Evidence that Cleavability of the Fusion Protein Is a Major Determinant for Virulence , 1999, Journal of Virology.

[10]  G. Thompson,et al.  Detection of positive selection in the major capsid protein VP60 of the rabbit haemorrhagic disease virus (RHDV). , 2008, Virus research.

[11]  Nick Goldman,et al.  Accuracy and Power of Statistical Methods for Detecting Adaptive Evolution in Protein Coding Sequences and for Identifying Positively Selected Sites , 2004, Genetics.

[12]  D. Haydon,et al.  Evidence for positive selection in foot-and-mouth disease virus capsid genes from field isolates. , 2001, Genetics.

[13]  Cuiping Song,et al.  Characterization of Pigeon-Origin Newcastle Disease Virus Isolated in China , 2006, Avian diseases.

[14]  N. Goldman,et al.  Codon-substitution models for heterogeneous selection pressure at amino acid sites. , 2000, Genetics.

[15]  Morten Nielsen,et al.  Improved method for predicting linear B-cell epitopes , 2006, Immunome research.

[16]  E. Kaleta,et al.  Newcastle disease outbreaks in recent years in Western Europe were caused by an old (VI) and a novel genotype (VII) , 1998, Archives of Virology.

[17]  Ziheng Yang.  PAML 4: phylogenetic analysis by maximum likelihood. , 2007, Molecular biology and evolution.

[18]  H. Wan,et al.  Pathotypical and genotypical characterization of strains of Newcastle disease virus isolated from outbreaks in chicken and goose flocks in some regions of China during 1985–2001 , 2003, Archives of Virology.

[19]  K. Tsukamoto,et al.  Phylogenetic Analysis of Newcastle Disease Virus Genotypes Isolated in Japan , 2002, Journal of Clinical Microbiology.

[20]  A. Scheid,et al.  Isolation and Purification of the Envelope Proteins of Newcastle Disease Virus , 1973, Journal of virology.

[21]  L. Tan,et al.  Pathotypical Characterization and Molecular Epidemiology of Newcastle Disease Virus Isolates from Different Hosts in China from 1996 to 2005 , 2007, Journal of Clinical Microbiology.

[22]  Michael P. Cummings,et al.  PAUP* [Phylogenetic Analysis Using Parsimony (and Other Methods)] , 2004 .

[23]  J. Kwang,et al.  Characterization of Newly Emerging Newcastle Disease Virus Isolates from the People's Republic of China and Taiwan , 2001, Journal of Clinical Microbiology.

[24]  R. Nielsen,et al.  Effect of recombination on the accuracy of the likelihood method for detecting positive selection at amino acid sites. , 2003, Genetics.

[25]  R. M. Iorio,et al.  Monoclonal antibodies to newcastle disease virus: delineation of four epitopes on the HN glycoprotein , 1983, Journal of virology.

[26]  R. Glickman,et al.  Genetic variation within a neutralizing domain on the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus. , 1986, The Journal of general virology.

[27]  W. Wong,et al.  Bayes empirical bayes inference of amino acid sites under positive selection. , 2005, Molecular biology and evolution.

[28]  Yuliang Liu,et al.  Identification of a variable epitope on the Newcastle disease virus hemagglutinin-neuraminidase protein. , 2010, Veterinary microbiology.

[29]  Simon A. A. Travers,et al.  Evidence for Heterogeneous Selective Pressures in the Evolution of the env Gene in Different Human Immunodeficiency Virus Type 1 Subtypes , 2005, Journal of Virology.

[30]  S. Elankumaran,et al.  The Hemagglutinin-Neuraminidase Protein of Newcastle Disease Virus Determines Tropism and Virulence , 2004, Journal of Virology.

[31]  V. Shnyrov,et al.  Sialidase, receptor-binding and fusion-promotion activities of Newcastle disease virus haemagglutinin-neuraminidase glycoprotein: a mutational and kinetic study. , 2004, The Journal of general virology.

[32]  R. Nielsen,et al.  Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. , 1998, Genetics.

[33]  Jae-Hong Kim,et al.  Variation of a Newcastle Disease Virus Hemagglutinin-Neuraminidase Linear Epitope , 2008, Journal of Clinical Microbiology.

[34]  A. Gould,et al.  Sequence variation in the Newcastle disease virus genome. , 2006, Virus research.

[35]  V. Shepherd,et al.  Virus glycosylation: role in virulence and immune interactions , 2007, Trends in Microbiology.

[36]  Jianpeng Ma,et al.  Diversifying selective pressure on influenza B virus hemagglutinin , 2009, Journal of medical virology.

[37]  F. Zhuang,et al.  Newcastle disease outbreaks in western China were caused by the genotypes VIIa and VIII. , 2002, Veterinary microbiology.

[38]  C. Afonso,et al.  Newcastle disease: evolution of genotypes and the related diagnostic challenges. , 2010, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[39]  David Posada,et al.  MODELTEST: testing the model of DNA substitution , 1998, Bioinform..

[40]  M. Nei,et al.  MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. , 2007, Molecular biology and evolution.

[41]  D. Swofford.  PAUP*: Phylogenetic analysis using parsimony (*and other methods), Version 4.0b10 , 2002 .